2021年10月14日

卫生部药物递送服务显示模糊的立场바로가기기자명金正日Chan-hyuk닫기政府采取了模棱两可的立场在药物递送服务,暂时允许由于Covid-19大流行。一方面,政府认识到药剂师和政客的批评,药可能造成不利影响。但是,另一方面,政府发誓要放宽法规促进远程医疗。政府官员和公司首席执行官出席“振兴创新创业的政府邀请会议”在Dreamplus Gangnam周三。周四,卫生部和福利、司法部、中小企业和创业公司参加了一个会议与药物传输服务提供商来促进创新创业。事件吸引了太多的关注,因为健康和福利部长会见了Doctornow,药物交付平台提供者,以来首次的国民议会最近的审计。从政府方面,司法部长公园Beom-kye,中小企业和创业公司部长Kwon Chil-seung,健康和福利第二Ryu Geun-hyuk副部长出席了会议。从行业、法律技术,Modu迹象,Codit加入了谈话。医疗平台提供者包括Doctornow、Goodoc MDSquare,愈合纸也参加了会议。韩国创业论坛(KSF),主持人,说会议旨在汇集政府和科技创业创新的法律和医疗共享业务困难,设法振兴基于平台的创业公司。 KSF said an amicable atmosphere was formed for platform-based startups at the event. According to KSF, the government, startup CEOs, and experts had Q&As on difficulties of operating drug delivery platforms and social disputes, discussed how to overcome them, and shared ideas freely to push for a reasonable policy. However, industry officials said the health and welfare ministry and Doctornow did not have in-depth conversations regarding the drug delivery service. Still, the ministry gave a positive signal about not easing the social distancing rule immediately, which could extend the temporary telemedicine and the drug delivery service, they said. “As various platform companies gathered, we could not talk much about drug delivery,” an official at Doctornow said. “But an official at the health ministry said the government would not lower the Covid-19 crisis level immediately even with ‘living with covid’ policy.” The Doctornow’s official said the legal basis for drug delivery would remain valid even if the health authorities started to use the “With Corona” policy. “Telehealth was a hot issue at the parliamentary audit, so we expect that the government and companies will have more discussions,” he added. Earlier at the parliamentary audit, Health and Welfare Minister Kwon Deok-cheol said, “Plans for a step-by-step return to normalcy include lowering the infectious disease crisis level.” He said the ministry would discuss it with the quarantine authorities. Asked by lawmakers whether the government had support measures for providers of contactless patient care, he said, “If telemedicine guaranteeing safety and efficacy has to be institutionalized for the benefit of the public, we should gather concerns of the medical community sufficiently and discuss it for related legislation in the National Assembly.”